×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
BriaCell Provides Update on Alleged Illegal Trading of Public Securities
Yahoo Finance
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT)...
2 months ago
BriaCell Showcases Cancer Immunotherapy Advances at ASCO - TipRanks.com
Tipranks
BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics Corp. is set to make significant contributions at the 2024 ASCO Annual Meeting...
1 week ago
BriaCell Announces Oral and Poster Presentations at ASCO 2024
GlobeNewswire
Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MDTwo poster presentations include Drs. Hurvitz...
1 week ago
BriaCell Shares Advance as Production of Lead Candidate Begins
MarketWatch
By Robb M. Stewart BriaCell Therapeutics' shares jumped Tuesday after the biotechnology company began manufacturing Bria-Pros+, its lead...
2 months ago
BriaCell Therapeutics (OTCMKTS:BCTXF) Stock Price Down 5.6%
Defense World
BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report)'s stock price traded down 5.6% during trading on Wednesday .
1 week ago
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer ...
GlobeNewswire
Agreement with a leading cancer treatment group to advance the clinical development of Bria-OTS+ (breast cancer) and Bria-PROS+ (prostate...
1 month ago
BriaCell's Bria-IMT™ Shows Groundbreaking Treatment Efficacy - TipRanks.com
Tipranks
BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics has reported promising clinical data for its product Bria-IMT™,...
3 weeks ago
BriaCell Therapeutics Corp. (TSE:BCT) Forecasted to Earn Q3 2024 Earnings of ($0.75) Per Share
Defense World
Read BriaCell Therapeutics Corp. (TSE:BCT) Forecasted to Earn Q3 2024 Earnings of ($0.75) Per Share at Defense World.
3 weeks ago
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
GlobeNewswire
Disease control rate of 61% observed in evaluable Phase 2 patients treated with the same formulation in BriaCell's pivotal Phase 3 study...
2 months ago
BriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in Advanced Metastatic Breast Cancer
Yahoo Finance
The randomized pivotal Phase 3 study is expected to enroll a total of 354 patients in either Bria-IMT™ combination or physician's choice...
7 months ago